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October 20111226 AbstractsIntroduction and objectives:Chronic kidney disease (CKD) is associated
with increased morbidity and death after open abdominal aortic aneurysm
(AAA) repair (OAR). This study highlights the effect ofCKDonoutcomes after
endovascular AAA repair (EVAR) and OAR in contemporary practice.
Methods: The National Surgical Quality Improvement Program Partici-
pant Use File (2005-2008) was queried by Current Procedural Terminology
code to identify EVAR or OAR patients who were grouped by CKD class as
having mild (class 1, 2), moderate (class 3), or severe (class 4, 5) renal disease.
Comparative analysis of mortality and clinical outcomes was performed based
on CKD strata.
Results: CKD increased (P  .01) overall mortality with rates of 1.7%
(mild), 5.3% (moderate), and 7.7% (severe) in unmatched patients. Rates in
severe patients were as high as 6.2% for EVAR and 10.3% for OAR.
Propensity matching to control for comorbidities was performed, resulting
in similar baseline clinical and demographic features of patients with mild
compared to those with moderate or severe disease. Even in matched
cohorts, moderate and severe CKD increased the risk of 30-day mortality
and complications compared with mild OAR and EVAR patients (Table I).
On regression analysis, moderate and severe CKD independently predicted
operative mortality and complications (Table II).
Conclusions: The presence of moderate or severe CKD in patients
considered for AAA repair is associated with significantly increased mortality
and therefore should figure prominently in clinical decision making.
Table I. Thirty-day outcomes in propensity-matched open
repair (OAR) and endovascular aneurysm repair (EVAR)
patients by degree of chronic kidney disease (CKD)
CKD degree
30-day mortality (%) Any complication (%)
EVAR OAR EVAR OAR
Mild 1.9 3.1 3.1 11
Moderate 3.2a 8.4a 8.4a 32a
Severe 5.7a 9.9a 9.9a 25a
aP  .01 compared with mild CKD.
Table II. Chronic kidney disease (CKD) independently
predicts mortality and complication risk
CKD
degree
30-day mortality Any complication
OR (95% CI) OR (95% CI)
EVAR OAR EVAR OAR
Moderate 1.7 (1.1-2.7)a 2.8 (1.8-4.5)a 1.6 (1.3-2.0)a 1.4 (1.2-1.8)a
Severe 1.5 (1.1-2.1)a 1.6 (1.1-2.3)a 1.4 (1.2-1.7)a 1.2 (1.01-1.4)a
CI, Confidence interval; EVAR, endovascular aneurysm repair; OAR, open
aneurysm repair; OR odds ratio.
aP  .05 compared with mild.
Utility of a Standardized Measurement Protocol to Simplify Case Plan-
ning for Branched-Fenestrated Endovascular Aortic Aneurysm Repair
Matthew Sweet, Mark Fillinger, Dartmouth Hitchcock Medical Center,
Lebanon, NH
Introduction and objectives: Standardization of branch vessel measure-
ment for branched-fenestrated endovascular aortic aneurysm repair could sim-
plify the teaching of patient selection, case planning, and device selection. The
purpose of this study was to determine (1) the accuracy of measurements
obtained by a novice nonclinician using a standardized computer-aided proto-
col, and (2) interobserver variability between an experienced clinician and a
clinical fellow.
Methods: Computed tomography angiographies from 60 patients
with 239 visceral branches of thoracoabdominal aortic aneurysms were
examined by three observers: a technologist using a novel computer-
aided standardized protocol, a trained clinical fellow, and a vascular
surgeon experienced in branched endograft repair. Measurements in-
cluded centerline distance between vessels, branch angle, lumen diame-
ter, and the resulting arc length for placement of the fenestration-branch
origin. Interobserver variability was measured by Bland-Altman method.
Results: Measurements obtained by the standard algorithm closely
matched those of experienced clinicians, with 99% of arc length measurements
4 mm and 96%3 mm. Two arc length measurements (0.8%) exceeded the
4-mm threshold: one due to scatter artifact and one due to extreme angulation.
Arc lengthmean errorwas –0.1mm(95% limits of agreement, –3.0 to 2.8mm),
S
Mnd accuracy was not related to the arc length. The interobserver comparison
etween clinicians found 96% agreement4 mm.
Conclusions: This standardized protocol demonstrated excellent
eliability, even when performed by a novice and when compared with
onstandardized measurements by experienced clinicians. Although it
epresents only a portion of case planning, this branch measurement
rotocol is simple and can be rapidly taught using workstations that
lready exist in most hospitals. We believe it will simplify the teaching of
atient selection, case planning, and device selection for branched fenes-
rated endovascular aneurysm repair.
ariation in Thromboembolic Complications Among Patients Under-
oing Commonly Performed Cancer Operations
andall R. De Martino,1 Philip P. Goodney,1 Emily L. Spangler,1 Jessica
. Wallaert,1 Samuel R. Finlayson,1 Matthew Corriere,2 Richard J.
owell,1 Eva M. Rzucidlo,1 Daniel B. Walsh,1 David H. Stone,1
Dartmouth-Hitchcock Medical Center, Lebanon, NH; 2Emory Univer-
ity School of Medicine, Atlanta, Ga
Introduction and objectives: There is widespread evidence that cancer
onfers an increased risk of deep venous thrombosis (DVT). This risk is
hought to vary among different cancer types. The purpose of this study was
o better define the incidence of thrombotic complications among patients
ndergoing surgical treatment for a spectrum of prevalent cancer diagnoses
n contemporary practice.
Methods: All patients undergoing one of ten cancer surgical opera-
ions (breast surgery, hysterectomy, prostatectomy, colectomy, gastrec-
omy, lung resection, hepatectomy, pancreatectomy, cystectomy, and
sophagectomy) were identified by Current Procedural Terminology and
nternational Classification of Diseases, 9th Revision, Clinical Modification
odes using the National Surgical Quality Improvement Program (NSQIP).
he primary end point was perioperative DVT. Secondary end points
ncluded pulmonary embolism (PE) and overall venous thromboembolic
vents (VTE) 1 month of the index procedure. Multivariate logistic
egression was used to calculate adjusted odds ratios for the primary end
oint.
Results: During the study interval (2007-2009), 42,842 of the se-
ected cancer operations were performed. The incidence of DVT, PE and
otal VTE1 month after surgery varied widely across a spectrum of cancer
iagnoses, from 0.19%, 0.12%, and 0.28% for breast resection to 6.1%, 2.4%,
nd 7.3%, respectively, for esophagectomy. Compared with breast cancer,
he incidence of thrombotic complications ranged from a 2.4-fold increase
n DVT associated with lung resection (95% confidence interval, 1.2-4.9,
 .017) to a 6.1-fold increase associated with esophagectomy (95%
onfidence interval, 3.3-11.4; P  .001; Table).
Conclusions: The incidence of DVT and thrombotic complications
ssociated with cancer surgery varies substantially. These findings suggest that
umor type and resection magnitude may both affect VTE risk. Accordingly,
uch data can be used to anticipate risk of potentially preventable morbid
omplications.
able. Incidence rates and odds ratios (OR) of venous
hromboembolism (VTE) among commonly performed
ancer operationsa
peration
Rate (per 1000 cases) OR (95% CI)
Adjusted for
DVTa PDVT, % (No.) VTE, % (N)
reast 1.9 (15) 2.8 (22) 1.0 (ref)
ung resection 12.8 (18) 23.4 (33) 2.4 (1.2-4.9) .017
rostatectomy 7.4 (22) 12.1 (36) 2.5 (1.3-5) .008
astrectomy 17.9 (42) 26.9 (63) 2.6 (1.4-4.8) .003
ancreatectomy 22.7 (125) 34.1 (188) 2.6 (1.4-4.6) .001
epatectomy 19.1 (71) 29.9 (111) 2.9 (1.6-5.3) .001
ystectomy 27.7 (9) 46.2 (15) 2.9 (1.6-5.3) .019
ysterectomy 11 (18) 17.8 (29) 3.5 (1.8-7.2) .001
olectomy 16.6 (267) 24.5 (394) 3.5 (2-5.8) .001
sophagectomy 60.6 (65) 72.8 (78) 6.1 (3.3-11.4) .001
I, Confidence interval; DVT, deep vein thrombosis.
ata derived fromNational SurgicalQuality ImprovementProgram (2007-2009).
Odds ratio adjusted for patient characteristics and preoperative, intraoper-
tive, and postoperative factors.
nitial Use of a Large-Bore Suction Thrombectomy Cannula For the Trea-
ent of Massive Inferior Vena Cava and Iliofemoral Deep Venous Throm-
osis
hirling Tsai, Mark F. Conrad, Virendra Patel, Christopher J. Kwolek,
assachusetts General Hospital, Boston, Mass
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Volume 54, Number 4 Abstracts 1227Introduction and objectives: Few options exist for treating patients with
massive inferior vena cava (IVC) and iliofemoral deep vein thrombosis (DVT)
and a contraindication to thrombolysis.Wepresent five patientswhounderwent
IVC/iliac mechanical venous thrombectomy using a novel intravascular device.
Methods:During a 6-month period, five patients underwent mechan-
ical aspiration thrombectomy of IVC/iliac venous occlusion using the
Vortex Angiovac system. A 22F cannula was placed into the iliac venous
system via bilateral femoral cutdowns. The cannula was connected to a
venovenous bypass circuit, and thrombus was trapped in a separate filter
(Fig). Anticoagulated blood was returned to the patient via a right internal
jugular venous cannula. Open thrombectomy was performed of the bilateral
lower extremity veins.
Results: Five patients presented with acute (3 months) IVC throm-
bosis, manifested by phlegmasia in three or debilitating lower extremity
swelling in two. All patients had a contraindication to thrombolytic therapy.
Four patients had documented hypercoagulable states and a previously
placed IVC filter. IVC thrombectomy was successful in all five patients.
Intravascular ultrasound (IVUS) identified residual stenosis in four patients,
which were successfully treated with Wallstents. Mean procedure time was
389 minutes. Patients were discharged at an average of 8.5 days postopera-
tively on full anticoagulation. There were no deaths. Lower extremity edema
significantly improved in all patients. Follow-up computed tomography scan
at a mean of 72 days showed continued patency of the IVC in all patients.
Conclusions: The Vortex AngioVac provides a safe and effective
alternative method for treating massive acute (3 months) IVC thrombosis
in patients with a contraindication to thrombolysis.
Use of a Postoperative Insulin Protocol Decreases Wound Infection in
Diabetic Patients Undergoing Lower Extremity Bypass
Fuyuki Hirashima,1 Reshma Patel,1 Julie E. Adams,1 Peter W. Callas,2 Daniel J.
Bertges,1 Georg Steinthorsson,1 Janet McSorley,1 Andrew C. Stanley,1 1Fletcher
AllenHealth Care, Burlington, Vt; 2University of Vermont, Burlington, Vt
Introduction and objectives: Strict glucose control in patients undergo-
ing coronary bypass grafting has been shown to decrease infectious complica-
tions, arrhythmias, and death. Our objective was to determine if strict glucose
control reduced morbidity after lower extremity bypass (LEB).
Methods:Aprospective pilot study at a single institutionwithin theVascular
Study Group of New England was conducted from January 2009 to December
2010. Diabetic and nondiabetic patients undergoing LEB received an insulin
infusion for 3 days after surgery, with titration of blood glucose to 80 to 120
mg/dL. The study group of 104 patients was compared with a historic control
group of 189 patients from the preceding 2 years. Fisher exact test, t tests, and 2,
and logistic regression analyses were used to compare in-hospital morbidity. Strati-
fied analyses were conducted to determine if findings differed by the presence or
absence of diabetes.
Results: There was no difference between the insulin infusion group
and historical control group with regard to graft infection, myocardial
infarction, dysrhythmias, primary patency at discharge, or mortality rate.
Patients in the intravenous insulin group had significantly fewer wound
infections (4% vs 11%; odds ratio [OR], 0.32; 95% confidence interval [CI],
0.11-0.96; P  .047). This association was strengthened after adjusting for
potentially confounding baseline differences in gender, body mass index,
and smoking status (adjusted OR, 0.22; 95% CI, 0.06-0.84; P .03). When
Fig. Thrombus was trapped in a separate filter.stratified by presence of diabetes, wound infections were decreased in the
insulin infusion group (0 of 44 [0%] vs 9 of 90 [10%], P  .03.) There was
3
Ao statistically significant difference in wound infection between nondiabetic
ndividuals in the insulin infusion group and the control group.
Conclusions: Strict glucose control with a postoperative insulin infu-
ion protocol significantly decreased the incidence of postoperative wound
nfection in all diabetic individuals undergoing LEB. These previously
nreported findings from this single-institution prospective study warrant
urther multi-institutional investigation.
lood Transfusion is Associated With Increased Perioperative Surgical
ite Infection and Graft Failure in Lower Extremity Bypass
ze-Woei Tan,1 Jeffrey Kalish,1 Alik Farber,1 Naomi Hamburg,1 Robert
berhardt,1 Gheorghe Doros,1 Denis Rybin,1 Jen Eldrup-Jorgensen,2
hilip Goodney,3 Jack L. Cronenwett,3 1Vascular Study Group of New
ngland, Boston Medical Center, Boston, Mass; 2Maine Medical Center,
ortland, Me; 3Dartmouth-Hitchcock Medical Center, Lebanon, NH
Introduction and objectives: Packed red blood cell transfusion has
een postulated to increase morbidity andmortality after cardiac and general
urgical operations, but its effects after lower extremity bypass (LEB) have
ot been studied extensively. Most studies have focused on the perioperative
eriod, but long-term effects of transfusion have not been elucidated.
Methods: Using the Vascular Study Group of New England database
2003-2010), we examined 2582 consecutive infrainguinal LEB procedures
erformed by 71 surgeons at academic and community hospitals on patients
ith claudication and critical limb ischemia (CLI). Perioperative transfusionwas
ategorized as 0 units, 1 to 2 units, and 3 units. Patients who received 3
nits were case-matched for age, coronary artery disease, diabetes, and urgency
f revascularization with patients who received 1 to 2 or 0 units. Primary end
ointswere perioperative death, surgical site infection (SSI), andgraft patency at
ischarge, as well as mortality, SSI, and graft patency at 1 year.
Results: In the case-matched sample, 514 LEB patients (63%) received 0
nits, 194 (23.8%) received 1 to 2 units, and 108 (13.2%) received3 units of
acked red blood cells. Transfusion was associated with significantly higher
erioperative SSI and return to the operating room and with a significantly
ower discharge patency rate (Table). At 1 year, no significant differences existed
n mortality, SSI, or graft patency. In multivariate analysis, after controlling for
ndication of CLI vs claudication, transfusion was still associated with increased
erioperative SSI (P .006) and graft failure at discharge (P .0001).
Conclusions: Perioperative transfusion in patients undergoing LEB is
ssociated with increased SSI and perioperative graft failure. From this observa-
ional study, it appears transfusion does not have significant long-term conse-
uences, but its detrimental effects in the perioperative periodmust be weighed
arefully against the presumed benefits of blood replacement.
able. Patient characteristics and outcomes of transfusion
Characteristica
0 units 1-2 units 3 units
P(n 514) (n 194) (n 108)
Age, mean  SD,
years
73.4  10.7 73.3  11.1 74.6  10.8 .52
Proportion with
Critical limb
ischemia
410 (79.8) 176 (90.7) 100 (92.6) .0001
Diabetes mellitus 364 (70.8) 142 (73.2) 78 (72.2) .81
Coronary artery
disease
259 (50.4) 96 (49.5) 53 (49.1) .97
Great saphenous
vein
339 (66) 121 (62.4) 65 (60.2) .36
Perioperative SSI 20 (3.9) 15 (7.7) 16 (14.8) .0001
Graft patency at
discharge
487 (96.1) 178 (91.8) 89 (84) .0001
1-year outcomes
Mortality 59 (14.5) 28 (18.7) 17 (23.3) .12
SSI 22 (7.9) 14 (15.2) 4 (10.3) .12
Graft patency 232 (70.3) 85 (72.6) 32 (61.5) .34
D, Standard deviation;SSI, Surgical site infection
Data are shown as number (%) unless indicated otherwise.
ostPerDayofPatency:Long-termImplicationsofPatency andReinterven-
ions After Endovascular vs Surgical Lower Extremity Revascularizations
anish Mehta, Fariha Ramay, Sean P. Roddy, Paul B. Kreienberg, Yaron Stern-
ach, Philip S.K. Paty, John B. Taggert, Kathleen J. Ozsvath, Benjamin B. Chang,
hiraj M. Shah, R. Clement Darling III, The Vascular Group, Albany, NY
Introduction and objectives: Using an amortized cost model, we
rospectively evaluated the long-term costs associated with all initial and
einterventions of lower extremity endovascular revascularization (ER)
nd surgical revascularization (SR) for femoropopliteal occlusive disease.
Methods: Since 2004, 183 patients with femoropopliteal occlusive
isease had ER (85 [46%]) or SR (98 [54%]) for claudication (44% ER vs
6% SR, P NS) or chronic limb ischemia (56% ER vs 64% SR, P NS).
n amortized cost model that included patency data end points and all
